Benzenesulphonamide compounds
US6541471B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2002 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | Jul 12, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I): wherein:G represents a group such as: wherein R1 and R2 independently represent a hydrogen atom or an alkyl, cycloalkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heteroaryl or heteroarylalkyl group, or,R1 and R2 together with the nitrogen atom form a heterocycloalkyl group,R3 represents a hydrogen atom or an alkyl or optionally substituted phenyl group,Ra represents a hydroxy group, a linear or branched (C1-C6)alkoxy group or an amino group,Rb and Rc, which may be identical or different, each represents a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, a hydroxy group or a trihaloalkyl group,m is an integer of from 0 to 1 inclusive,n and q are integers of from 0 to 6 inclusive,p and r are integers of from 1 to 6 inclusive,its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base; and medicinal products containing the same which are useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.